Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana María Rodríguez-Leboeuf"'
Autor:
Ulf-Henrik Mellqvist, H. Tilman Steinmetz, Aurore Perrot, Erik Aerts, Paul Williams, Ana Vallejo, Kate Morgan, Ananda Plate, Ana María Rodríguez-Leboeuf, Renaud Desgraz, Eva Hellqvist Franck, Lucy De Costa, Alessandra Brescianini, Heinz Ludwig
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:e240-e251.e12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b02c6eb43f6e5dfb068550886f5ff39a
https://doi.org/10.1016/j.clml.2023.02.010
https://doi.org/10.1016/j.clml.2023.02.010
Autor:
Paulo Alves, Carla Pais-Vieira, Ana Caramelo, Miguel Pais-Vieira, Alexandra Palmer Minton, Ana María Rodríguez-Leboeuf, Vasco Silva-Neves
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 18, Iss 5793, p 5793 (2021)
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
International Journal of Environmental Research and Public Health
Volume 18
Issue 11
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
International Journal of Environmental Research and Public Health
Volume 18
Issue 11
(1) Background: Onychomycosis (OM) is a fungal nail infection, considered a risk factor for diabetic foot ulcers. It is associated with changes in quality of life, in terms of pain, self-confidence and self-esteem. The aim was to translate and adapt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a72233cfc7ed0dd17d8a01d5d0a7e1fc
https://www.mdpi.com/1660-4601/18/11/5793
https://www.mdpi.com/1660-4601/18/11/5793
Autor:
Audrey Delmas, Laurie Batchelder, Ira Arora, Solene Bayet, David Bruhn, Alice Eberhardt, Stephanie Philpott, Ana Maria Rodriguez-Leboeuf
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionAbout half of patients with Acute Myeloid Leukemia (AML) are not eligible for Standard Induction Chemotherapy (SIC). Hypomethylating Agents (HMAs) intravenously (IV) or subcutaneously (SC) in a clinical setting are typically offered as an
Externí odkaz:
https://doaj.org/article/684d919f7c7b47a9b587140af15cbb82